Skip to main content
High RiskFDAfda-F-1308-2019CONTAMINATION

DG health NATURALS For Infants 2+ Months+ baby Cough Syrup + Mucus, Natural Grape Flavor, 2 FL OZ (59 mL), UPC: 8 54954 00250 0, Product...

Units Affected
15,240
Recall Date
March 20, 2019
Issuing Agency
Hazard
Contamination

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1308-2019.

Microbial contamination with Bacillius circulans and Bacillus cereus / thuringiensis / mycoides.

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1308-2019.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Kingston Pharma Llc or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1308-2019.

Kingston Pharma LLC

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Kingston Pharma Llc Recall FAQ

Kingston Pharma Llc is the subject of a baby food & formula safety report: DG health NATURALS For Infants 2+ Months+ baby Cough Syrup + Mucus, Natural Grape Flavor, 2 FL OZ (59 mL), UPC: 8 54954 00250 0, Product.... The notice was published on March 20, 2019 by the U.S. Food and Drug Administration (FDA). Approximately 15,240 units are potentially affected.